Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2021 May 13;13(10):2353.
doi: 10.3390/cancers13102353.

The Gut Microbiome and Gastrointestinal Toxicities in Pelvic Radiation Therapy: A Clinical Review

Byeongsang Oh  1   2   3 , Thomas Eade  1   2   3 , Gillian Lamoury  1   2   3 , Susan Carroll  1   2   3 , Marita Morgia  1   2 , Andrew Kneebone  1   2   3 , George Hruby  1   2   3 , Mark Stevens  1   2 , Frances Boyle  2   3 , Stephen Clarke  1   3 , Brian Corless  1 , Mark Molloy  4 , David Rosenthal  5 , Michael Back  1   2   3
Affiliations
Review

The Gut Microbiome and Gastrointestinal Toxicities in Pelvic Radiation Therapy: A Clinical Review

Byeongsang Oh et al. Cancers (Basel). .

Abstract

Background: Gastrointestinal (GI) toxicities are common adverse effects of pelvic radiotherapy (RT). Several recent studies revealed that toxicity of RT is associated with dysbiosis of the gut microbiome.

Method: A literature search was conducted in electronic databases Medline, PubMed, and ScienceDirect, with search terms "microbiome and/or microbiota" and "radiotherapy (RT) and/or chemoradiation therapy (CRT)" and "cancer", and the relevant literature were selected for use in this article.

Results: Eight prospective cohort studies were selected for review with a total of 311 participants with a range of 15-134 participants within these studies. The selected studies were conducted in patients with gynaecological (n = 3), rectal (n = 2), or prostate cancers (n = 1), or patients with various types of malignancies (n = 2). Three studies reported that cancer patients had significantly lower alpha diversity compared with healthy controls. Seven studies found that lower alpha diversity and modulated gut microbiome were associated with GI toxicities during and after pelvic RT (n = 5) and CRT (n = 2), whereas one study found that beta diversity was related to a complete response following CRT. Two further studies reported that fatigue was associated with dysbiosis of the gut microbiome and low alpha diversity during and after RT, and with dysbiosis of the gut microbiome and diarrhoea, respectively.

Conclusion: Gut microbiome profiles are associated with GI toxicities and have the potential to predict RT/CRT-induced toxicities and quality of life (QoL) in patients undergoing those treatments. Further robust randomized controlled trials (RCTs) are required to elucidate the effect of gut microbiome profiles on RT-related adverse effects and responses to RT.

Keywords: cancer; chemoradiotherapy; gastrointestinal toxicities; gut microbiome; radiotherapy.

PubMed Disclaimer

Conflict of interest statement

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Figures

Figure 1
Figure 1
Preferred reporting items for systematic review and meta-analysis.
See this image and copyright information in PMC

References

    1. Allison R.R., Patel R.M., McLawhorn R.A. Radiation oncology: Physics advances that minimize morbidity. Future Oncol. 2014;10:2329–2344. doi: 10.2217/fon.14.176. - DOI - PubMed
    1. Barton M.B., Jacob S., Shafiq J., Wong K., Thompson S.R., Hanna T.P., Delaney G.P. Estimating the demand for radiotherapy from the evidence: A review of changes from 2003 to 2012. Radiother Oncol. 2014;112:140–144. doi: 10.1016/j.radonc.2014.03.024. - DOI - PubMed
    1. Stokman M.A., Spijkervet F.K.L., Boezen H.M., Schouten J.P., Roodenburg J.L.N., de Vries E.G.E. Preventive Intervention Possibilities in Radiotherapy- and Chemotherapy-induced Oral Mucositis: Results of Meta-analyses. J. Dent. Res. 2006;85:690–700. doi: 10.1177/154405910608500802. - DOI - PubMed
    1. Villa A., Sonis S.T. Mucositis: Pathobiology and management. Curr. Opin. Oncol. 2015;27:159–164. doi: 10.1097/CCO.0000000000000180. - DOI - PubMed
    1. Bultman S.J. Emerging roles of the microbiome in cancer. Carcinogenesis. 2013;35:249–255. doi: 10.1093/carcin/bgt392. - DOI - PMC - PubMed

LinkOut - more resources